Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201111195 Principal Investigator: Tabchy, Adel
Title: A randomized multicenter, double-blind, placebo-controlled comparison of chemotherapy plus trastuzumab plus placebo versus chemotherapy plus trastuzumab plus pertuzumab as adjuvant therapy in patients with operable HER2-positive primary breast cancer
Phase: III Disease Site: Breast, Female
Participating Site(s):
 
Main Campus
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
This study will assess the safety and efficacy of pertuzumab in addition to chemotherapy plus Herceptin as adjuvant therapy in patients with operable HER2-positive primary breast cancer.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)